Latest Breaking News On - Life sciences at exyte - Page 1 : comparemela.com

Exyte named as general contractor (EPCQ contract partner) Project is part of the German government's program to prepare for future pandemics Implementation in less than 24 months thanks to ExyCell modular system Lighthouse project for the strategic growth segment of Biopharma and Life Sciences at Exyte Biotechnology and personalized medicine drive growth Exyte CEO Bchele: "Better medical care, faster healing processes, a higher life expectancy - all this facilitated with the support of Exyte." STUTTGART, July 8, 2022 /PRNewswire/ Exyte GmbH (Exyte), a global leader in the design, engineering and delivery of facilities for high-tech industries, is building a mRNA competence center at the Halle Biotech site of Wacker Chemie AG (WACKER). The project is making a considerable contribution towards strengthening the Biopharma and Life Sciences segment at Exyte as well as to the company's ambitious "Pathway to Ten" growth path. Today, a breaking of ground ceremon

Irene zieglerWolfgang bcheleMelanie ksmarkerPrnewswire exyte gmbhView research instituteGerman federal ministry of healthLife sciences at exyteCorporate communicationsLife sciencesCentre for pandemic vaccinesHalle biotechWacker chemieWacker biotechWeinberg campusPandemic vaccinesGerman federal ministry